{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:04:49Z","timestamp":1648559089818},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00105-018-4317-0","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T08:02:46Z","timestamp":1554969766000},"page":"2-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["69\/m mit wei\u00dfen, nicht abwischbaren Plaques am Penis"],"prefix":"10.1007","volume":"70","author":[{"given":"Alexander","family":"Kreuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Oellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Silling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"key":"4317_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00430-003-0181-2","volume":"193","author":"G Gross","year":"2004","unstructured":"Gross G, Pfister H (2004) Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193:35\u201344","journal-title":"Med Microbiol Immunol"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1046\/j.1365-2133.2002.05019.x","volume":"147","author":"WM Porter","year":"2002","unstructured":"Porter WM, Francis N, Hawkins D, Dinneen M, Bunker CB (2002) Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol 147:1159\u20131165","journal-title":"Br J Dermatol"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1038\/jid.2008.72","volume":"128","author":"A Kreuter","year":"2008","unstructured":"Kreuter A, Brockmeyer NH, Weissenborn SJ et al (2008) Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J\u00a0Invest Dermatol 128:2316\u20132324","journal-title":"J Invest Dermatol"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.semdp.2011.08.009","volume":"29","author":"EF Velazquez","year":"2012","unstructured":"Velazquez EF, Chaux A, Cubilla AL (2012) Histologic classification of penile intraepithelial neoplasia. Semin Diagn Pathol 29:96\u2013102","journal-title":"Semin Diagn Pathol"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.meegid.2013.03.011","volume":"18","author":"HU Bernard","year":"2013","unstructured":"Bernard HU (2013) Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect Genet Evol 18:357\u2013361","journal-title":"Infect Genet Evol"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K et\u00a0al (2009) A review of human carcinogens \u2013 part B: biological agents. Lancet Oncol 10:321\u2013322","journal-title":"Lancet Oncol"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00105-015-3630-0","volume":"66","author":"U Wieland","year":"2015","unstructured":"Wieland U, Kreuter A (2015) HPV-induced anal lesions. Hautarzt 66:439\u2013445","journal-title":"Hautarzt"},{"issue":"11","key":"4317_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamadermatol.2016.2503","volume":"152","author":"A Kreuter","year":"2016","unstructured":"Kreuter A, Siorokos C, Oellig F, Silling S, Pfister H, Wieland U (2016) High-grade dysplasia in anogenital warts of HIV-positive men. JAMA Dermatol 152(11):1225\u20131230","journal-title":"JAMA Dermatol"},{"key":"4317_CR9","first-page":"242","volume":"16","author":"GE Gross","year":"2018","unstructured":"Gross GE, Werner RN, Becker JC et al (2018) S2k guideline: HPV-associated lesions of the external genital region and the anus \u2013 anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version). J\u00a0Dtsch Dermatol Ges 16:242\u2013255","journal-title":"J Dtsch Dermatol Ges"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/CCO.0000000000000211","volume":"27","author":"JM Brotherton","year":"2015","unstructured":"Brotherton JM, Ogilvie GS (2015) Current status of human papillomavirus vaccination. Curr Opin Oncol 27:399\u2013404","journal-title":"Curr Opin Oncol"},{"key":"4317_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0950268815002198","volume":"144","author":"PE Castle","year":"2016","unstructured":"Castle PE, Maza M (2016) Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect 144:449\u2013468","journal-title":"Epidemiol Infect"},{"key":"4317_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","volume":"16","author":"AR Kreimer","year":"2015","unstructured":"Kreimer AR, Struyf F, Del Rosario-Raymundo MR et al (2015) Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol 16:775\u2013786","journal-title":"Lancet Oncol"},{"key":"4317_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S et\u00a0al (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N\u00a0Engl J Med 364:401\u2013411","journal-title":"N Engl J Med"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S et\u00a0al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N\u00a0Engl J Med 365:1576\u20131585","journal-title":"N Engl J Med"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura EA, Giuliano AR, Iversen OE et al (2015) A 9\u2011valent HPV vaccine against infection and intraepithelial neoplasia in women. N\u00a0Engl J Med 372:711\u2013723","journal-title":"N Engl J Med"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1016\/j.vaccine.2015.06.088","volume":"33","author":"X Castellsague","year":"2015","unstructured":"Castellsague X, Giuliano AR, Goldstone S et al (2015) Immunogenicity and safety of the 9\u2011valent HPV vaccine in men. Vaccine 33:6892\u20136901","journal-title":"Vaccine"},{"key":"4317_CR17","series-title":"Epidemiologisches Bulletin 34","volume-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut \u2013 2018\/2019","year":"2018","unstructured":"RKI (Hrsg) (2018) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut \u2013 2018\/2019. Epidemiologisches Bulletin 34"},{"key":"4317_CR18","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","volume":"36","author":"J Schiller","year":"2018","unstructured":"Schiller J, Lowy D (2018) Explanations for the high potency of HPV prophylactic vaccines. Vaccine 36:4768\u20134773","journal-title":"Vaccine"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00120-018-0593-7","volume":"57","author":"C Colberg","year":"2018","unstructured":"Colberg C, van der Horst C, J\u00fcnemann KP et\u00a0al (2018) Epidemiology of penile cancer. Urologe A 57:408\u2013412","journal-title":"Urologe A."},{"key":"4317_CR20","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/ijc.29082","volume":"136","author":"AR Giuliano","year":"2015","unstructured":"Giuliano AR, Nyitray AG, Kreimer AR et al (2015) EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer 136:2752\u20132760","journal-title":"Int J Cancer"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T23:34:20Z","timestamp":1586475260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4317-0"}},"subtitle":["Vorbereitung auf die Facharztpr\u00fcfung: Folge\u00a027"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":20,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4317-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"11 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Kreuter hat Referentenhonorare von Sanofi Pasteur MSD und MSD SHARP & DOHME erhalten und war im Advisory Board von Sanofi Pasteur MSD und MSD SHARP & DOHME t\u00e4tig. F.\u00a0Oellig, S.\u00a0Silling und U.\u00a0Wieland geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}